Peter J Barnes
Peter J Barnes is an expert in Pulmonology at Imperial College London (United Kingdom). As of October 2026, ScienceLeadR ranks Peter J Barnes in the top 1% of experts worldwide for Asthma, Hypersensitivity and Lung Diseases, Obstructive. Peter J Barnes has authored 1,850 publications, the most recent in 2026, and is an investigator in 25 clinical trials. SLR score: 6,758 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Immunology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Professor Sir Peter Barnes DM, DSc, FRCP, FCCP, FMedSci, FRS
Peter Barnes is Professor of Thoracic Medicine at the National Heart and Lung Institute was Head of Respiratory Medicine at Imperial College London 1987-2017. He qualified at Cambridge and Oxford Universities (first class honours) and trained in London. He has published >1500 peer-review papers on asthma, COPD and respiratory pharmacology (h-index 230, >200,000 citations) and has written/edited >50 books. He is in the top 100 most highly cited researchers in the world and has been the most highly cited respiratory researcher in the world over the last 30 years. He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for >150 years. He has given several prestigious lectures, including Amberson Lecture at American Thoracic Society and Sadoul Lecture at European Respiratory Society. He was President of the ERS in 2013/2014. He was awarded the Trudeau Medal by the ATS in 2020 and knighted in 2023 for services to respiratory science. Professor Barnes does research on the mechanisms and treatment of asthma and COPD and is currently working on the role of cellular senescence in chronic lung diseases.
Organizations
Career arc: 1987 - 2026
Number : 1850
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Insights into extracellular vesicles in senescence-associated chronic lung diseases. PMID 42438973 — extracellular vesicles, lung, fibrosis, aging, disease progression, prevalence, immunity, therapeutics, lung diseases, tissues | Chin Med J (Engl) | 2026 | 1 |
| Asthma therapy over 100 years. PMID 42328736 — injections, bronchodilator agents, antibodies, adrenal cortex hormones, theophylline, therapeutics, asthma, biological therapy, steroids | Postgrad Med J | 2026 | 0 |
| The crucial role of normative ageing in respiratory pathogenesis. PMID 42044655 — respiratory system, healthy aging | Lancet Healthy Longev | 2026 | 0 |
| Clearance of Senescent Cells by BCL XL-PROTAC: A Novel Approach to Treat COPD? PMID 41979382 — cells, lung, epithelial cells, pulmonary disease, chronic obstructive, fibroblasts, therapeutics, apoptosis | Aging Cell | 2026 | 0 |
| EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care. PMID 41868650 — hypersensitivity, research, rhinitis, asthma, education, rhinosinusitis, allergy | Front Allergy | 2026 | 0 |
Clinical Studies 25
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map